Characterization of cytochrome P450-mediated drug metabolism in cats

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2007, Pages 422-428

  Shah, S S ^a   Sanda, S ^a   Regmi, N L ^a   Sasaki, K ^a   Shimoda, M ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUFURALOL; CYTOCHROME P450 1A; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 3A; ETHOXYRESORUFIN DEETHYLASE; MIDAZOLAM; QUINIDINE; TOLBUTAMIDE;

ARTICLE; CAT; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; IN VITRO STUDY; MALE; MICHAELIS MENTEN KINETICS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CATS; CYTOCHROME P-450 ENZYME SYSTEM; ETHANOLAMINES; FEMALE; HYPNOTICS AND SEDATIVES; HYPOGLYCEMIC AGENTS; MALE; MICROSOMES, LIVER; MIDAZOLAM; OXAZINES; TOLBUTAMIDE;

RATTUS;

EID: 34548409108     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00902.x     Document Type: Article

References (26)

1. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248 254.
2. Burke, M.D., Prough, R.A. Mayer, R.T. (1977) Characteristics of a microsomal cytochrome P-448-mediated reaction, ethoxyresorufin O-deethylation. Drug Metabolism and Disposition, 5, 1 8.
3. Chauret, N., Gauthier, A., Martin, J. Nicoll-Griffith, D.A. (1997) In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metabolism and Disposition, 25, 1130 1136.
4. Cochrane, S.M., Parent, J.M., Black, W.D., Allen, D.G. Lumsden, J.H. (1990) Pharmacokinetics of phenobarbital in the cat following multiple oral administration. Canadian Journal of Veterinary Research, 54, 309 312.
5. Gregus, Z., Watkins, J.B., Thompson, T.N., Harvey, M.J., Rozman, K. Klaassen, C.D. (1983) Hepatic phase I and II biotransformations in quail and trout: comparison to the other species commonly used in toxicity testing. Toxicology Applied Pharmacology, 67, 430 441.
6. van der Hoeven, T.A. Coon, M.J. (1974) Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. Journal of Biological Chemistry, 249, 6302 6310.
7. Hojo, T., Ohno, R., Shimoda, M. Kokue, E. (2002) Enzyme and plasma protein induction by multiple oral administrations of phenobarbital at a therapeutic dosing regimen in dogs. Journal of Veterinary Pharmacology and Therapeutics, 25, 121 127.
8. Kamali, F., Ball, D.E., McLaughlin, W.S. Seymour, R.A. (1999) Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth. Journal of Periodontal Research, 34, 145 153.
9. Khalil, W.F., Saitoh, T., Shimoda, M. Kokue, E. (2001) In vitro cytochrome P450-mediated hepatic activities for five substrates in specific pathogen free chickens. Journal of Veterinary Pharmacology and Therapeutics, 24, 343 348.
10. Kobayashi, K., Urashima, K., Shimada, N. Chiba, K. (2002) Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology, 63, 889 896.
11. Kronbach, T., Mathys, D., Gut, J., Catin, T. Meyer, U.A. (1987) High- performance liquid chromatographic assay for bufuralol 1-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-deethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Analytical Biochemistry, 162, 24 32.
12. Kuroha, M., Kuze, Y., Shimoda, M. Kokue, E. (2002a) In vitro characterization of the inhibitory effects of Ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes. American Journal of Veterinary Research, 63, 900 905.
13. Kuroha, M., Azumano, A., Kuze, Y., Shimoda, M. Kokue, E. (2002b) Effect of multiple dosing of ketoconazole on pharmacokinetics of midazolam, a cytochrome P-450 3A substrate in beagle dogs. Drug Metabolism and Disposition, 30, 63 68.
14. Matar, K.M., Nicholls, P.J., Bawazir, S.A., Al-Hassan, M.I. Tekle, A. (2000) Effect of vigabatrin and gabapentin on phenytoin pharmacokinetics in the dog. Pharmacology Research, 42, 517 521.
15. Miners, J.O., Smith, K.J., Robson, R.A., McManus, M.E., Veronese, M.E. Birkett, D.J. (1988) Tolbutamide hydroxylation by human liver microsomes; Kinetic characterization and relationship to other cytochrome P-450 dependent xenobiotics oxidations. Biochemical Pharmacology, 37, 1137 1144.
16. Newton, D.J., Wang, R.W. Lu, A.Y. (1995) Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154 158.
17. Omura, T. Sato, R. (1964) The carbon monoxide binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370 2378.
18. Perloff, M.D., von Moltke, L.L., Court, M.H., Kotegawa, T., Shader, R.I. Greenblatt, D.J. (2000) Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. Journal of Pharmacology and Experimental Therapeutics, 292, 618 628.
19. Roye, D.B., Serrano, E.E. Hammer, R.H. (1973) Plasma kinetics of diphenylhydantoin in dogs and cats. American Journal of Veterinary Research, 34, 947 950.
20. Sharer, J.E., Shipley, L.A., Vandenbranden, M.R., Binkley, S.N. Wrighton, S.A. (1995) Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231 1241.
21. Shimada, T., Mimura, M., Inoue, K., Nakamura, S., Oda, H., Ohmori, S. Yamazaki, H. (1997) Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Archives of Toxicology, 71, 401 408.
22. Szotáková, B., Baliharová, V., Lamka, J., Nožinová E., Wsól V., Velík J., Machala M., Neča J., Souček P., Šusová S. Skálová L. (2004) Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science, 76, 43 51.
23. Tanaka, N., Miyasho, T., Shinkyo, R., Sakaki, T. Yokota, H. (2006) cDNA cloning and characterization of feline CYP1A1 and CYP1A2. Life Sciences, 79, 2463 2473.
24. Tobin, T., Dirdjosudjono, S. Baskin, S.I. (1973) Pharmacokinetics and distribution of diphenylhdantoin in kittens. American Journal of Veterinary Research, 34, 951 954.
25. Umehara, K., Shimokawa, Y. Miyamoto, G. (2002) Effect of probucol on cytochrome P450 activities in human liver microsomes. Biological Pharmacology Bulletin, 25, 1112 1114.
26. Yamaoka, K., Tanigawara, Y., Nakagawa, T. Uno, T. (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. Journal of Pharmacobiodynamics, 4, 879 885.